Philip J. Mease, MD: New Data on Guselkumab for Psoriatic Ar

This interview segment with Dr. Mease featured a discussion about data presented at ACR 2023 on guselkumab and patients with psoriatic arthritis.

Related Keywords

Spondyloarthritis Ps , Philipj Mease , , University Of Washington School Medicine , Swedish Medical Center , American College Of Rheumatology , Drug Administration , Janssen Pharmaceuticals Inc , Corevitas Psoriatic Arthritis , Spondyloarthritis Registry , Janssen Pharmaceuticals , Washington School , Patient Reported Outcomes Through , Guselkumab Treatment , Patients With Active Psoriatic Arthritis , Real World Data From , Corevitas Psoriatic , Novel Psoriatic Arthritis , Thermometer Scale , Domains During Treatment , Pooled Analysis , Three Phase , Accessed November , Racr , Guselkumab , Psoriatic Arthritis , Psa , Mease ,